Skip to content

Decision support for couples with hereditary diseases and child wish: weighing pros and cons of reproductive options regarding transmission of gene mutations.

Decision support for couples with hereditary diseases and child wish: weighing pros and cons of reproductive options regarding transmission of gene mutations.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON25214
Enrollment
256
Registered
2021-04-15
Start date
2021-05-03
Completion date
Unknown
Last updated
2024-02-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hereditary Diseases

Interventions

Decision aid with written and visual information, including value clarification methods (VCMs).

Sponsors

MUMC+/Maastricht University
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: One of the partners has an autosomal dominant hereditary condition, an X-linked condition, a chromosomal anomaly or both partners are carrier of an autosomal recessive condition for which all reproductive options are available in the Netherlands, participants should have an active child wish (within 5 years), and the female partner should be of reproductive age (18-41 years). Additionally, couples should have sufficient knowledge of the Dutch language and ample experience with the use of computers and internet.

Exclusion criteria

Exclusion criteria: Being pregnant at time of inclusion.

Design outcomes

Primary

MeasureTime frame
Decisional conflict. This will be assessed by means of the Decisional Conflict Scale (O’Connor, 1995).

Secondary

MeasureTime frame
Secondary outcome measures include knowledge and realistic expectations of different reproductive options (e.g. accuracy of perceived risks), deliberation (van den Berg et al., 2006), attitude , joint informed decision-making and preparation for decision making (Bennett et al., 2010). The Multidimensional Measure of Informed Choice (MMIC; Marteau et al., 2001) will be used to assess informed choice.

Contacts

Public ContactYil Severijns

Maastricht University

yil.severijns@maastrichtuniversity.nl+31 43 3882404

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP)